Search Within

Steven M Larson

Formats
  1. Journal Article (544)
  2. Meeting Abstract (350)
  3. Book Section (29)
  4. Conference Paper (23)
  5. Editorial (5)
  6. Review (4)
  7. Book Whole (3)
  8. Miscellaneous (1)
Groups
  1. GSK Faculty (959)
  2. Molecular Imaging and Therapy Service (959)
  3. Molecular Pharmacology and Chemistry Program Faculty (959)
  4. Radiology, Department of (959)
  5. Sloan Kettering Institute Faculty (959)
  6. Department of Medicine (386)

More Groups

People
  1. John Humm (185)
  2. Ronald Finn (184)
  3. Pat Zanzonico (112)
  4. Howard Scher (110)
  5. Nai-Kong Cheung (108)
  6. Chaitanya Divgi (103)

More People

Years
  1. 2025 (6)
  2. 2024 (8)
  3. 2023 (11)
  4. 2022 (23)
  5. 2021 (14)
  6. 2020 (18)

More Years

Publications
  1. Journal of Nuclear Medicine (294)
  2. Journal of Clinical Oncology (84)
  3. Clinical Cancer Research (34)
  4. Cancer Research (29)
  5. European Journal of Nuclear Medicine (24)
  6. European Journal of Nuclear Medicine and Molecular Imaging (22)

More Publications

Publishers
  1. Society of Nuclear Medicine (294)
  2. American Society of Clinical Oncology (85)
  3. American Association for Cancer Research (83)
  4. Springer (77)
  5. Elsevier Inc. (49)
  6. Lippincott Williams & Wilkins (31)

More Publishers

Results (959)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Application of a multiplexed fluorescence microscopy method (MultiOmyx (TM)) to dissect proteomic biomarkers of (18)F-fluorodeoxy-glucose ((18)FDG) uptake in breast cancer
    Meeting Abstract

    Sood, A.; Miller, A. M.; Ginty, F.; McDonough, E.; Sui, Y. X.; Bordwell, A.; Li, Q.; Kaanumalle, S.; Pang, Z. Y.; Torres, F.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Carrasquillo, J. A.; Danila, D. C.; Beylergil, V.; O'Donoghue, J. A.; Cheal, S. M.; Ruan, S. T.; Pandit-Taskar, N.; Fox, J. J.; Fleming, S. E.; Zanzonico, P. B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save
  • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
    Journal Article

    Phillips, E.; Penate-Medina, O.; Zanzonico, P. B.; Carvajal, R. D.; Mohan, P.; Ye, Y.; Humm, J.; Gonen, M.; Kalaigian, H.; Schòˆder, H.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Molecular imaging for localized prostate cancer: Analysis of 2 prospective phase 0 trials of PSMA targeted immuno-PET and -SPECT, and implications for the radiation oncologist
    Meeting Abstract

    Spratt, D. E.; Fareedy, S.; Lindgren, S.; Robinson, B.; Larson, S. M.; Lewis, J.; Bander, N. H.; Scherr, D. S.; Osborne, J. R.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex
    Journal Article

    Cheal, S. M.; Xu, H.; Guo, H. F. ; Zanzonico, P. B.; Larson, S. M.; Cheung, N. K.
    Molecular Cancer Therapeutics (2014)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of bone metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled anti-prostate specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; Beylergil, V.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy
    Journal Article

    Osborne, J. R.; Green, D. A.; Spratt, D. E.; Lyashchenko, S.; Fareedy, S. B.; Robinson, B. D.; Beattie, B. J.; Jain, M.; Lewis, J. S.; Christos, P.; more...
    Journal of Urology (2014)

    Fulltext@MSK | Save
  • Pairwise comparison of (89)Zr- and (124)I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: In vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma
    Journal Article

    Cheal, S. M.; Punzalan, B.; Doran, M. G.; Evans, M. J.; Osborne, J. R.; Lewis, J. S.; Zanzonico, P.; Larson, S. M.
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save